Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration...